![](/wp-content/uploads/2018/10/DM45JgCUS32bmcNQbm7D.png)
$599
Sema to Replace Metformin as 1L in T2DM?
As a follow-up to Novo’s oral semaglutide ASCEND PLUS primary prevention CVOT being posted to CT.gov (previous FENIX insight), FENIX has conducted an analysis, including thoughts on how Novo may be looking to displace metformin as 1L oral treatment for T2DM.